Numerous studies have demonstrated that biallelic mutations in PALB2 resulted in a subtype of Fanconi anemia (FA-N), while monoallelic PALB2 mutations predispose carriers to multiple cancers such as breast, pancreatic, and ovarian cancers (5–8). The gene discussed is PALB2; the disease is ovarian carcinoma.